Wang T, Hirons A, Doerflinger M, Morris K, Ledger S, Purcell D
Viruses. 2024; 16(10).
PMID: 39459949
PMC: 11512412.
DOI: 10.3390/v16101616.
Hleihel R, Skayneh H, de The H, Hermine O, Bazarbachi A
Blood Cancer J. 2023; 13(1):67.
PMID: 37137914
PMC: 10156663.
DOI: 10.1038/s41408-023-00841-7.
Zhang W, Wang D, Si J, Jin L, Hao Y
Cells. 2023; 12(4).
PMID: 36831328
PMC: 9954825.
DOI: 10.3390/cells12040661.
El Hajj H, Bazarbachi A
Front Immunol. 2022; 13:957535.
PMID: 35935975
PMC: 9352851.
DOI: 10.3389/fimmu.2022.957535.
Ernzen K, Panfil A
Biosci Rep. 2022; 42(3).
PMID: 35169839
PMC: 8919135.
DOI: 10.1042/BSR20211921.
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.
Forlani G, Shallak M, Accolla R, Romanelli M
Int J Mol Sci. 2021; 22(15).
PMID: 34360767
PMC: 8347336.
DOI: 10.3390/ijms22158001.
as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases.
Madi J, Al Outa A, Ghannam M, Hussein H, Shehab M, Hasan Z
Front Immunol. 2021; 12:586930.
PMID: 33828545
PMC: 8019809.
DOI: 10.3389/fimmu.2021.586930.
as a Model for Infectious Diseases.
Harnish J, Link N, Yamamoto S
Int J Mol Sci. 2021; 22(5).
PMID: 33800390
PMC: 7962867.
DOI: 10.3390/ijms22052724.
In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ.
Akkouche A, Moodad S, Hleihel R, Skayneh H, Chambeyron S, El Hajj H
PLoS Pathog. 2021; 17(1):e1009219.
PMID: 33471856
PMC: 7817025.
DOI: 10.1371/journal.ppat.1009219.
The Leukemic Fly: Promises and Challenges.
Al Outa A, Abubaker D, Madi J, Nasr R, Shirinian M
Cells. 2020; 9(7).
PMID: 32708107
PMC: 7409271.
DOI: 10.3390/cells9071737.
Novel Treatments of Adult T Cell Leukemia Lymphoma.
El Hajj H, Tsukasaki K, Cheminant M, Bazarbachi A, Watanabe T, Hermine O
Front Microbiol. 2020; 11:1062.
PMID: 32547515
PMC: 7270167.
DOI: 10.3389/fmicb.2020.01062.
Validation of a model of wild-type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: an effective platform for treatment screening.
Al Outa A, Abubaker D, Bazarbachi A, El Sabban M, Shirinian M, Nasr R
Haematologica. 2019; 105(2):387-397.
PMID: 31101753
PMC: 7012492.
DOI: 10.3324/haematol.2019.219394.
40 years of the human T-cell leukemia virus: past, present, and future.
Tagaya Y, Matsuoka M, Gallo R
F1000Res. 2019; 8.
PMID: 30854194
PMC: 6396841.
DOI: 10.12688/f1000research.17479.1.
The HTLV-1 oncoprotein Tax is modified by the ubiquitin related modifier 1 (Urm1).
Hleihel R, Khoshnood B, Dacklin I, Omran H, Mouawad C, Dassouki Z
Retrovirology. 2018; 15(1):33.
PMID: 29665857
PMC: 5904992.
DOI: 10.1186/s12977-018-0415-4.
Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia.
Moodad S, Akkouche A, Hleihel R, Darwiche N, El-Sabban M, Bazarbachi A
Front Microbiol. 2018; 9:558.
PMID: 29643841
PMC: 5882783.
DOI: 10.3389/fmicb.2018.00558.
Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.
Dubuisson L, Lormieres F, Fochi S, Turpin J, Pasquier A, Douceron E
Oncogene. 2018; 37(21):2806-2816.
PMID: 29507418
DOI: 10.1038/s41388-018-0163-x.
HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.
Futsch N, Mahieux R, Dutartre H
Viruses. 2017; 10(1).
PMID: 29267225
PMC: 5795414.
DOI: 10.3390/v10010001.
HTLV-1 Tax Functions as a Ubiquitin E3 Ligase for Direct IKK Activation via Synthesis of Mixed-Linkage Polyubiquitin Chains.
Wang C, Long W, Peng C, Hu L, Zhang Q, Wu A
PLoS Pathog. 2016; 12(4):e1005584.
PMID: 27082114
PMC: 4833305.
DOI: 10.1371/journal.ppat.1005584.